Medanta net profit surges over five-fold to Rs 101 cr in March quarter

For the financial year ended on March 31, 2023, Medanta posted a net profit of Rs 326 crore as against Rs 196 crore in FY22


Image source: Medanta website

New Delhi

Listen to This Article

Healthcare provider Global Health (Medanta) on Monday said its net profit surged over five fold to Rs 101 crore in the fourth quarter ended on March 31, 2023, aided by increase in bed capacity and higher in-patient footfalls.
The company had reported a net profit of Rs 17.5 crore in the January-March quarter of 2021-22 fiscal.
Revenue in the reporting quarter rose 37 per cent year-on-year to Rs 732 crore, the company said in a statement.
For the financial year ended on March 31, 2023, Medanta posted a net profit of Rs 326 crore as against Rs 196 crore in FY22.
Revenue rose to Rs 2,759 crore in the last fiscal as against Rs 2,206 crore in 2021-22 fiscal.
"For the year and quarter ending March 31, 2023 we have registered significant growth and strong financial performance across all revenue and profitability metrics," Global Health Group CEO and Director Pankaj Sahni noted.

Also Read

US venture capitalists hope Budget 2023 supports growth, startup ecosystem

'India believes in democratized access to all digital health solutions'

India emerging as favourable place to conduct medical trials: PwC India

Travelling to Gurgaon from Delhi today? Read this traffic advisory

Bihar Cabinet approves Rs 309 cr for construction of AIIMS-Darbhanga

Xiaomi partners Optiemus to manufacture audio products in Noida

Atomberg raises $86 mn in series C funding from Temasek, Steadview Capital

Ola launches 'Prime Plus' cabs for cancellation-free rides; details here

JioCinema, NBCUniversal sign partnership pact to bring NBCU films to India

ONGC Videsh has around $100 mn of dividend income stuck in Russia: Official

The healthcare provider continues its planned growth in beds and infrastructure, and remain an attractive destination for leading clinical talent, which is highlighted by the addition of over 150 senior clinicians in the last fiscal year, he added.
Shares of the company ended 1.05 per cent higher at Rs 594.10 apiece on the BSE.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: May 29 2023 | 4:33 PM IST

Explore News